|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.81M 4.64M 4.33M 3.93M 7.4M 503M 7.47M 51.97M 20.33M 256M 19.51M 19.09M 822M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.33M 8.7M 7.91M 14.88M 1.01B 15.02M 104M 40.86M 514M 39.22M 38.37M 1.65B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| -0.50% | +1.72% | +38.30% | +106.93% | 1,043B | |
| +0.16% | -0.84% | +35.21% | +62.70% | 618B | |
| +0.79% | +4.81% | +17.81% | +83.77% | 481B | |
| +0.35% | -0.99% | +64.79% | +37.06% | 351B | |
| +1.81% | +3.76% | +22.17% | +42.99% | 338B | |
| +1.28% | +2.36% | +11.69% | +35.12% | 269B | |
| +1.24% | +1.87% | -6.55% | +11.39% | 244B | |
| +0.65% | +0.04% | +38.29% | +52.33% | 220B | |
| +0.64% | -0.27% | +24.40% | +96.82% | 182B | |
| Average | +0.71% | +0.28% | +27.34% | +58.79% | 374.67B | |
| Weighted average by Cap. | +0.43% | +0.60% | +30.68% | +69.27% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.94M 7.41M 6.73M 12.66M 861M 12.79M 88.94M 34.79M 438M 33.39M 32.66M 1.41B | 9.91M 116M 8.85M 8.26M 7.5M 14.11M 960M 14.25M 99.11M 38.77M 488M 37.21M 36.4M 1.57B |
| Net income | 665K 7.78M 594K 554K 503K 947K 64.41M 956K 6.65M 2.6M 32.73M 2.5M 2.44M 105M | 762K 8.91M 680K 634K 576K 1.08M 73.76M 1.1M 7.62M 2.98M 37.48M 2.86M 2.8M 121M |
| Net Debt | 4.15M 48.53M 3.7M 3.45M 3.14M 5.91M 402M 5.96M 41.48M 16.22M 204M 15.57M 15.23M 656M | 5.25M 61.44M 4.69M 4.37M 3.97M 7.48M 508M 7.55M 52.51M 20.54M 258M 19.71M 19.28M 831M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
